"omega-N-Methylarginine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive inhibitor of nitric oxide synthetase.
| Descriptor ID |
D019323
|
| MeSH Number(s) |
D12.125.068.050.650 D12.125.095.104.650 D12.125.142.087.500
|
| Concept/Terms |
omega-N-Methylarginine- omega-N-Methylarginine
- omega N Methylarginine
- NG-Monomethyl-L-Arginine
- NG Monomethyl L Arginine
- L-NMMA
- L-Monomethylarginine
- L Monomethylarginine
- N(G)-Monomethylarginine
- D-NMMA
- N(G)-Monomethyl-D-Arginine
- N(omega)-Monomethyl-L-Arginine
- L-NG-Monomethyl Arginine
- Arginine, L-NG-Monomethyl
- L NG Monomethyl Arginine
- N(G)-Methylarginine
|
Below are MeSH descriptors whose meaning is more general than "omega-N-Methylarginine".
Below are MeSH descriptors whose meaning is more specific than "omega-N-Methylarginine".
This graph shows the total number of publications written about "omega-N-Methylarginine" by people in this website by year, and whether "omega-N-Methylarginine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "omega-N-Methylarginine" by people in Profiles.
-
Preserved ß-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2022 01 01; 322(1):H25-H35.
-
Nitric oxide synthase inhibition in healthy adults reduces regional and total cerebral macrovascular blood flow and microvascular perfusion. J Physiol. 2021 11; 599(22):4973-4989.
-
L-NAME releases nitric oxide and potentiates subsequent nitroglycerin-mediated vasodilation. Redox Biol. 2019 09; 26:101238.
-
Phosphodiesterase-5 inhibition preserves exercise-onset vasodilator kinetics when NOS activity is reduced. J Appl Physiol (1985). 2018 02 01; 124(2):276-282.
-
ß-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2016 Mar 15; 310(6):H756-64.
-
Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase. Eur J Appl Physiol. 2015 Aug; 115(8):1735-46.
-
The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Am J Pathol. 2009 Jan; 174(1):34-43.
-
Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am J Respir Crit Care Med. 1998 Jun; 157(6 Pt 1):1943-50.
-
TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol. 1994 Dec 01; 153(11):5141-7.
-
The role of nitric oxide in endotoxin-elicited hypodynamic circulatory failure. Adv Exp Med Biol. 1994; 366:412-3.